Allergan and it's new company that just purchased it has alot of money in the research department so if they do get good results from the trial to the point where investors are satisfied(let's say minoxidil gives 10% growth, BIM will probably need to achieve 20-25% growth minimum for investors to want to push forward with a phase III, just a guess not saying that's exactly what's needed). Then Phase III would start within a few months and they could even simply do a 6 month trial instead of year.
So essentially, best case scenario christmas 2015, worst case probably end of 2016 if they still push forward with phase III.
So essentially, best case scenario christmas 2015, worst case probably end of 2016 if they still push forward with phase III.
Comment